Meridian Bioscience New Products Posted to GenomeWeb: Centogene, Meridian Bioscience, Oxford Nanopore, More Meridian Bioscience Fiscal Q2 Revenues Up 49 Percent Despite the overall revenue increase, revenues from Meridian's diagnostic segment were down 9 percent. NIH RADx Program Awards $29.3M to Increase SARS-CoV-2 Testing Capacity The contracts are for two lateral flow rapid antigen tests, a laboratory-based test to detect and identify SARS-CoV-2 variants, and a rapid RT-PCR test. GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock The GenomeWeb Index underperformed the Dow Jones and the Nasdaq, but outperformed the Nasdaq Biotechnology Index last month. Meridian Withdraws Emergency Use Authorization Application to FDA for Coronavirus MDx Test The company, which had received a request from the FDA for more information on the test, is planning additional studies before resubmitting the application. Feb 16, 2021 Meridian Shares Drop as Much as 15 Percent on FDA Questions About SARS-CoV-2 Test Feb 5, 2021 Meridian Bioscience Fiscal Q1 Revenues Rise 96 Percent Feb 3, 2021 Meridian Bioscience Receives $5.5M From NIH to Expand SARS-CoV-2 Test Production Jan 7, 2021 Meridian Bioscience Preliminary Fiscal 2021 Q1 Revenues Up 94 Percent Dec 16, 2020 Meridian Bioscience Receives $1M NIH Grant for SARS-CoV-2 Test Launch Nov 13, 2020 Meridian Bioscience Q4 Revenues Climb 26 Percent, Beat Street Estimate Oct 26, 2020 Moving From Reagents Supplier to Test Developer, Meridian Bio Expands Role During COVID-19 Pandemic Premium Sep 1, 2020 Meridian Bioscience Leads Decliners in August as GenomeWeb Index Falls 4 Percent Aug 27, 2020 As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit Aug 7, 2020 Meridian Bioscience Fiscal Q3 Revenues Soar 75 Percent on COVID-19-Related Life Sciences Growth Jul 2, 2020 Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020 Jul 1, 2020 Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index Jun 1, 2020 Fluidigm Leads May GenomeWeb Index on Early Detection SARS-Cov-2 Blood Test Collaboration Details May 22, 2020 People in the News: Tony Serafini-Lamanna, Martin Chavez, Sun Kim, Oved Amitay, More May 11, 2020 William Blair Upgrades Meridian Bioscience to Outperform May 8, 2020 Meridian Bioscience Posts 14 Percent Revenue Increase in Fiscal Q2, Raises FY2020 Guidance May 1, 2020 GenomeWeb Index Recovers in April as Life Science Industry Focuses on Coronavirus Test Development Apr 2, 2020 Meridian Bioscience Preliminary Q2 Revenues Up 14 Percent Feb 7, 2020 Meridian Bioscience Fiscal Q1 Revenues Fall 8 Percent Jan 27, 2020 Meridian Stock Rises 21 Percent After Reagent Mix Used in Coronavirus Testing Load More Breaking News Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.